However, treatment with SCA at 5 or 10 mg/kg body weight in ISO-injected rats resulted in a significant (p < 0.05) reduction in serum levels of CK-MB, cTnI, and BNP compared to ISO-only rats. This evidence concerns the gene TNNI3 and autosomal dominant cerebellar ataxia.